Organizing Parties
__Society for Tropical Veterinary Medicine (STVM)
The Society for Tropical Veterinary Medicine (STVM) is a non-profit organization whose purpose is the advancement of tropical veterinary medicine, hygiene and related disciplines. The activities of the Society focus scientific interest on strategies to deal with established and changing patterns of diseases affecting animals in the tropics. Tropical Veterinary Medicine has become an area of global importance as world trade continues to expand and the challenge of future research is to develop better diagnosis, treatment and control methods for tropical diseases of livestock species. Significantly, a part of this is to understand the environmental variables which affect the host and disease interactions as well, and ultimately to support increased food production in the tropics. |
_Arbo-Zoonet
Arbo-Zoonet is the International Network for Capacity Building for the Control of Emerging Viral Vector Borne Zoonotic Diseases. It is a Coordination Action funded by the European Union (EU) under FP7 and was launched in May 2008. The project aims at promoting an international network for capacity building for the control of emerging vector borne zoonotic diseases, in particular West Nile, Rift Valley fever and Crimean-Congo hemorrhagic fever. Specifically, the network addresses integrated control measures including vector control, vaccination programmes and therapy strategies, diagnostic tools and surveillance, public awareness and capacity building in endemic regions. |
Collaborators
PiroVac
PiroVac is a major international EU-funded research project designed to develop control measures to combat two major tick-borne diseases of small ruminants, namely theileriosis and babesiosis. This research programme aims at improving existing vaccines, designing new vaccines and capacity building in partner laboratories both in Europe and in endemic areas. The PiroVac project was developed as an integrated approach, encompassing immunology, molecular biology, bioinformatics and genetic engineering together with pathogen genomics and host genetics which is directed at addressing two broad aims: (1) Development of effective and reliable vaccines for use in disease control campaigns for sustainable livestock development. (2) Capacity-building for the sustainable implementation of integrated control measures required for disease control and/or eradication through increasing scientific knowledge, training and improvement of infrastructure. PiroVac is funded by the European Union (EU) under FP7_ and was launched in 2010. |
_CCH FEVER
CCH FEVER is a European research network (Collaborative Project) coordinated by the Swedish Institute for Infectious Disease Control (SMI, Prof. Ali Mirazimi, Stockholm – Sweden). The consortium brings together 14 complementary partners, including 2 private companies and 12 laboratories, from 10 Member States and Associated Countries of the EU, as well as USA and South-Africa. The project is supported by the European Commission under the Health Priority of the 7th Research Framework Programme. |
__POSTICK
POSTICK is an Initial Training Network (ITN) funded through the EU Marie Curie actions of FP 7. POSTICK aims to design new effective control strategies for TTBD diseases through understanding the mechanisms of tick-host-pathogen interactions regarding: (a) pathogen diversity, survival and transmission, modulation of host immune response and tick survival and (b) identification of host-pathogen-tick molecules for designing anti-tick vaccine and blocking pathogen transmission. |
Italian Society for Virology
The Italian Society for Virology (SIV) is a non-profit Association founded in September 2001. The SIV has a multidisciplinary organization and merges the scientific and teaching interests of general, medical, pharmaceutical, veterinary and vegetal virologists. The aims of the SIV are to promote the knowledge and progress in virological research, to organize meetings and courses, to expand and connect the experience in virology to other related fields, with particular regard to biotechnology. The SIV is a Corporate Member of the European Society for Virology. |